Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-06-22 Purchase |
2022-06-22 4:55 pm |
Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman and CEO |
30,000 | $0.57 | $17,100 | 210,207 (Indirect Direct) |
View |
2021-04-20 Purchase |
2021-04-21 3:18 pm |
Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman, CEO & President |
11,005 | $1.8 | $19,809 | 180,207 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman and CEO |
375,000 | $0 | 375,000 (Direct) |
View |
2020-06-06 Option Award |
2020-06-08 9:26 pm |
N/A 2030-06-06 |
Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman, President & CEO |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
2020-05-22 Other |
2020-05-27 6:04 pm |
2020-05-22 2024-01-31 |
Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman, President & CEO. |
257,760 | $0 | 426,952 (Direct) |
View |